Select Page

South Delhi Pharma, New Delhi, India

AVSOLA (infliximab-axxq) for injection, for intravenous use

(18 customer reviews)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email to discuss.

AVSOLA is a prescription medicine. AVSOLA is used to treat arthritis, CD, UC and skin disease.
AVSOLA is a tumor necrosis factor (TNF) blocker indicated for:
Crohn’s Disease, Pediatric Crohn’s Disease, Ulcerative Colitis, Pediatric Ulcerative Colitis, Rheumatoid Arthritis in combination with methotrexate, Ankylosing Spondylitis, Psoriatic Arthritis.
For injection: 100 mg of lyophilized infliximab-axxq in a 20 mL single-dose vial for intravenous infusion.
Manufactured By: Amgen Medical Information
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “AAVSOLA (infliximab-axxq) for injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. It is given by slow injection into a vein, typically at six- to eight-week intervals.

Infliximab was approved for medical use in the United States in 1998, and in the European Union in August 1999. Infliximab biosimilars have been approved in the EU (2013), in Japan (2014), and in the United States (2016, 2017, 2019).

18 reviews for AVSOLA (infliximab-axxq) for injection, for intravenous use

  1. abogados comunidades de propietarios madrid

    You made some nice points there. I did a search on the topic and found most people will agree with your website.

  2. abogados expertos en construccion

    Keep working ,splendid job!

  3. wedding photographer

    Some times its a pain in the ass to read what blog owners wrote but this internet site is real user genial! .

  4. branding madrid

    Very clean web site, regards for this post.

  5. Ktszid

    sildenafil ca – sildenafil 100mg tablet buy viagra 150mg online

  6. Wiwbqg

    prednisolone 20mg price – prednisolone 20mg drug cialis walmart

  7. Noampm

    order augmentin sale – order cialis 10mg pill brand cialis

  8. Otzigz

    buy trimethoprim for sale – order bactrim 480mg pill viagra 100mg price

  9. Wincjq

    order cephalexin 250mg online – purchase erythromycin online cheap buy erythromycin for sale

  10. Ithhvj

    buy sildenafil 100mg online – fildena brand ivermectin otc

  11. Hityzw

    rhinocort online buy – tadalafil pills buy disulfiram 500mg pills

  12. Kerprx

    cefuroxime 250mg canada – purchase cefuroxime pills cost of cialis

  13. Tjiqvy

    buy acillin without prescription – cipro 1000mg canada tadalafil 10mg generic

  14. cbd öl testsieger schweiz

    I?¦ve recently started a web site, the information you provide on this web site has helped me greatly. Thanks for all of your time & work.

  15. Lwigxx

    buy amoxil for sale – order levitra 20mg brand levitra

  16. Hvhobb

    ivermectin lice oral – buy levitra online vardenafil brand

  17. Kzrkur

    doxycycline 200mg price – doxycycline price buy tadalafil online

  18. Kttkdu

    cialis 5mg pill – canadian pharcharmy modafinil order online

Add a review

Your email address will not be published.